Celecoxib enhanced the sensitivity of cancer cells to anticancer drugs by inhibition of the expression of P-glycoprotein through a COX-2-Independent Manner
Author:
Publisher
Wiley
Subject
Cell Biology,Molecular Biology,Biochemistry
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1002/jcb.22239/fullpdf
Reference49 articles.
1. Celecoxib induces apoptosis by inhibiting 3-phosphoinositide-dependent protein kinase-1 activity in the human colon cancer HT-29 cell line;Arico;J Biol Chem,2002
2. The potential role of cyclooxygenase-2 inhibitors in the treatment of experimentally-induced mammary tumour: Does celecoxib enhance the anti-tumour activity of doxorubicin?;Awara;Pharmacol Res,2004
3. Role of prostaglandin E2-dependent angiogenic switch in cyclooxygenase 2-induced breast cancer progression;Chang;Proc Natl Acad Sci USA,2004
4. COX-2 inhibition is neither necessary nor sufficient for celecoxib to suppress tumor cell proliferation and focus formation in vitro;Chuang;Mol Cancer,2008
5. SP1 activates the MDR1 promoter through one of two distinct G-rich regions that modulate promoter activity;Cornwell;J Biol Chem,1993
Cited by 32 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Drug Repurposing and Molecular Insights in the Fight Against Breast Cancer;Biomedical and Pharmacology Journal;2024-06-25
2. Perspectives of the Application of Non-Steroidal Anti-Inflammatory Drugs in Cancer Therapy: Attempts to Overcome Their Unfavorable Side Effects;Cancers;2023-01-12
3. Drugs repurposed: An advanced step towards the treatment of breast cancer and associated challenges;Biomedicine & Pharmacotherapy;2022-01
4. COX-2 promotes mammary adipose tissue inflammation, local estrogen biosynthesis, and carcinogenesis in high-sugar/fat diet treated mice;Cancer Letters;2021-04
5. The crucial role of epigenetic regulation in breast cancer anti-estrogen resistance: Current findings and future perspectives;Seminars in Cancer Biology;2020-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3